Keratosis Pilaris Clinical Trial
Official title:
A Placebo-Controlled, Double-Blind, Bi-Lateral Study to Evaluate the Performance and Tolerability of a Cosmetic Product Designed to Improve the Appearance of Skin Afflicted With Keratosis Pilaris
The purpose of this study is to demonstrate the safety, tolerability and efficacy of AO+ Mist administered daily for 4 weeks to improve the appearance of skin afflicted with keratosis pilaris.
This will be a single center, double-blind, placebo-controlled study in subjects with
keratosis pilaris affecting both sides of the body.
Subjects will be screened within 4 weeks of enrollment. Subjects will be seen at the research
facility on for the baseline visit and will be asked to return to the site on weeks 1, 2, 3
and 4 for assessments. Test product application will occur for four weeks starting with the
day of the baseline visit.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05666011 -
Laser to Aid in Treatment of Keratosis Pilaris on Arms
|
N/A | |
| Completed |
NCT04797663 -
Long-pulsed 1064 nm Nd-YAG Laser Versus TCA 20% in Treatment of Keratosis Pilaris
|
Phase 4 | |
| Terminated |
NCT00944216 -
Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
|
Phase 4 | |
| Active, not recruiting |
NCT06032078 -
Evaluation of the Responsiveness of Investigator Global Assessment Score for Keratosis Pilaris
|
N/A | |
| Recruiting |
NCT05535517 -
Development and Validation of an Investigator Global Assessment Score for Keratosis Pilaris
|